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Mast cell chymase expression and mast cell phenotypes in flammatory cells, intimal thickening of intrarenal arteries,
human rejected kidneys. tubular atrophy, and interstitial fibrosis [1, 2]. Although
Background. Mast cells (MCs) are known to participate in inflammatory cells such as macrophages and T lympho-various types of chronic disease, but their role in chronic renal
cytes increase in rejected renal allografts, it has beenrejection is poorly understood. Recently, distinct phenotypes
reported that mast cells (MCs) also increase in the renalof MCs have been described in humans by the demonstration
of one protease, chymase. Hence, we questioned whether chy- parenchyma of rejected renal allografts [3–5].
mase in MCs could play a role in the pathogenesis of renal Mast cells are thought to play a role in the pathogene-
rejection in humans. sis of a variety of chronic inflammatory diseases. Ac-Methods. We investigated MC chymase expression and MC
cording to their neutral protease content, human MCsphenotypes, using immunohistochemical single- and double-
have been divided into two phenotypes: those that con-staining techniques, in nephrectomy (N 5 13) and biopsy (N 5
8) specimens of human rejected kidneys. Tissue chymase levels tain only tryptase, termed MCt, and those that contain
were determined by enzymatic assay for chymase activity. We tryptase and chymase, termed MCtc [6]. These MC phe-
also examined the association between MC chymase expression notypes exhibit variable distribution, a spectrum of pro-
and the degree of interstitial fibrosis in these renal allografts.
tease content and differing responsiveness to activatingResults. Based on chymase positivity, rejected kidneys were
stimuli [7–9], suggesting that MC subtypes have differentdivided into two groups, a chymase-negative [Chy(2)] group
and a chymase-positive [Chy(1)] group. Quantitative analysis functions in health and disease, although these functions
showed that the number of chymase-positive MCs and tissue remain to be elucidated. Evidence for a new MC pheno-
chymase levels were significantly higher in the Chy(1) group type, designated MCc, which contains chymase but not
than in the Chy(2) group. Furthermore, the interstitial fibrotic
tryptase, has been shown in several human tissuesarea in the Chy(1) group was significantly larger than that in
[10–12]. More recently, in vitro studies have shown thatthe Chy(2) group. Immunodouble staining analysis also dem-
onstrated that a new MC phenotype, positive for chymase but interleukin-4 (IL-4) promotes morphological maturation
negative for tryptase, was present in the human rejected kidney. of human cultured MCs in accord with the increase in
Conclusions. These results show that increased expression chymase expression [13, 14]. These data suggest that
of chymase in MCs is related to the severity of interstitial fibro-
cytokines within the microenvironment may influencesis in human rejected kidneys.
the chymase expression of human MCs in vivo.
It is known that the identification of MCs is not easy in
routinely processed paraffin-embedded tissue sections.In human kidney transplantation, chronic rejection is a
However, a more reliable method of detection was re-major cause of morbidity and mortality among transplant
cently provided with the introduction of MC protease-recipients. Chronic renal rejection is histologically char-
specific monoclonal antibodies. With use of an anti-MCacterized by interstitial infiltration of mononuclear in-
antibody, Lajoie et al demonstrated for the first time
that tryptase-positive MCs increased in number in hu-
man renal allografts [5]. In their study, however, theKey words: tryptase, chymase, mast cells, kidney rejection, transplanta-
tion, angiotensin II, interleukin-4, renal allograft, interstitial fibrosis. identification of MCs was based only on an anti-MC
tryptase antibody. Therefore, MC phenotypes were notReceived for publication September 30, 1998
seen by these authors.and in revised form October 6, 2000
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Table 1. Relevant clinical data form, and 10% glacial acetic acid). This method of fixa-
tion has the advantage that immunohistochemical studiesInterval between
Interval between transplant/ on chymase expression can be performed on paraffin-
Age transplant/ nephrectomy embedded sections [6]. All biopsy specimens from renalCase no. years Gender hemodialysis or biopsy
allografts were also fixed in methanol-Carnoy’s fixative.
Nephrectomy specimens
Normal renal tissues obtained from four autopsied pa-N-1 27 F 3 mo 4 mo
N-2 37 F 3 mo 4 mo tients, including snap-frozen samples and tissue blocks
N-3 43 F 6 mo 8 mo fixed in methanol-Carnoy’s fixative, were examined asN-4 24 F 1 mo 1 yr 8 mo
controls.N-5 43 M 2 yr 4 mo 3 yr 4 mo
N-6 42 M 3 yr 3 yr 6 mo Tissue blocks, obtained from each transplanted or nor-
N-7 32 F 4 yr 5 mo 4 yr 6 mo mal kidney and fixed in methanol-Carnoy’s fixative, wereN-8 37 F 4 yr 5 mo 5 yr 3 mo
routinely processed and embedded in paraffin. ThirtyN-9 39 F 4 yr 5 mo 6 yr 7 mo
N-10a 43 M 8 yr 1 mo 8 yr 2 mo serial sections were cut from each block at 3 mm thick-
N-11 38 M 7 yr 1 mo 8 yr 5 mo ness. Every first and second sections were stained withN-12 52 M 5 yr 8 mo 8 yr 5 mo
hematoxylin and eosin and Azan Mallory stain, respec-N-13 30 F 11 yr 4 mo 12 yr 6 mo
Biopsy specimens tively. To identify MCs histologically, every third and
B-1 16 M — 2 yr
fourth sections were stained with astra-blue/safraninB-2 46 M — 3 yr
B-3 48 M — 4 yr 4 mo stain and toluidine blue stain, respectively [15]. The other
B-4 44 M — 4 yr 11 mo sections were used for immunohistochemical staining.
B-5a 42 M — 7 yr
The snap-frozen samples were serially sectioned at 5 mm
Abbreviations are: mo, months; yr, years; M, male; F, female.
thickness and fixed in acetone. Every first section wasa Nephrectomy specimen N-10 and biopsy specimen B-5 were obtained from
the same patient stained with hematoxylin and eosin, and the other sec-
tions were used for immunohistochemical staining.
Immunohistochemistry
have not been reported. For this reason, we studied the
Antibodies. The primary antibodies used for the iden-phenotypic expression of MCs using immunohistochemi-
tification of MCs were anti-MC tryptase (AA1; Dako,cal analysis and the tissue chymase levels, using an enzy-
A/S, Glostrup, Denmark) [16], anti-MC chymase (MAB-matic assay for chymase activity, in human transplanted
1254; Chemicon, Temecula, CA, USA) [17] and anti–c-kitkidneys. We also examined the association between MC
(Dako) [18]. Anti-macrophage antibodies (HAM56 andchymase expression and degree of interstitial fibrosis,
EBM11; Dako) were used for the identification of macro-and the relationship between MC chymase expression
phages. For endothelial cell identification, two antibodiesand IL-4 expression in human transplanted kidneys.
(F8/86, Dako; and EN-4, Monosan, Am Uden, The Neth-
erlands) were used. To identify T lymphocytes, two
METHODS anti-T lymphocyte antibodies, UCHL-1 (Dako) and
Leu4 (Becton and Dickinson, San Jose, CA, USA), wereThis study was based on an analysis of 13 renal allografts
used. For the identification of IL-4, anti–IL-4 antibodythat had been surgically removed because of chronic re-
(Genzyme, Cambridge, MA, USA) was used.jection and 5 renal biopsy specimens obtained from pa-
Single staining. Sections were incubated with the pri-tients with chronic rejection. The relevant clinical data
mary antibodies either overnight at 48C or for one hourare summarized in Table 1. In the nephrectomy cases,
at room temperature. The antibodies against c-kit, mac-11 patients had received a cadaveric kidney, and 2 re-
rophage (EBM11), endothelial cell (EN-4), T lymphocyteceived a kidney from a living-related donor. In the biopsy
(Leu4), and IL-4 did not work well with methanol Car-cases, all patients had received a cadaveric kidney. The
noy’s fixed sections and were used only on frozen sections.nephrectomy specimen of case N-10 and the biopsy spec-
The labeled streptavidin-biotin complex system withimen of case B-5 were obtained from the same patient
3-amino-9-ethylcarbazole color development was used.(Table 1). All patients were on triple immunosuppressive
Sections were faintly counterstained with hematoxylin.therapy (cyclosporine, prednisone, and azathioprine or
The specificity and results obtained with anti-MC tryp-mizoribine).
tase and chymase antibodies were checked by omittingFrom each nephrectomy specimen from renal allografts,
the primary antibodies and using a nonimmune mousefive tissue blocks were obtained; two blocks were snap
IgG antibody (Dako) as negative control.frozen and used for immunodouble staining and enzy-
Immunodouble staining. To identify cell types that ex-matic assay for chymase activity (discussed later in this
press chymase, tryptase, or IL-4, we performed immuno-article), and the remaining three blocks were fixed in
methanol-Carnoy’s fixative (60% methanol, 30% chloro- double staining. Moreover, for the identification of c-kit
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expression in chymase-positive cells, some sections were neys was also assessed, using sections stained with Azan-
Mallory stain. In this analysis, the surface area showingdouble stained with c-kit and chymase.
In immunodouble staining for EN-4/chymase, EBM11/ interstitial fibrosis within the cortex of the allograft was
quantitated, using the computerized morphometry sys-chymase, c-kit/chymase, IL-4/chymase, or tryptase/chy-
mase, one primary unlabeled antibody (EN-4, EBM11, tem, and was expressed as a percentage of the surface
area involved.c-kit, IL-4, or tryptase) and one biotinylated antibody
(chymase) were used according to modifications of pro- The observer was blind to data regarding the patients’
characteristics. Intraobserver variability was determinedcedures previously reported [19]. The following incu-
bations were performed in subsequent order: primary on the basis of triplicate measurements. The mean 6 SE
difference among measurements was 3.4 6 0.93%.unlabeled antibody, peroxidase-conjugated goat anti-
mouse immunoglobulin (Dako), normal mouse serum
Enzymatic assay for chymase activity(Dako), biotinylated chymase antibody (Chemicon), and
alkaline phosphatase-conjugated streptavidin (Dako). Chymase activity in normal kidney tissues or ne-
phrectomy specimens of rejected kidneys was measuredFinally, peroxidase was visualized with 3-amino-9-ethylc-
arbazole (red: EN-4, EBM11, c-kit, IL-4 and tryptase) by incubating tissue extracts for 10 minutes at 378C
with 770 mmol/L of angiotensin I as the substrate, inand alkaline phosphatase with fast blue BB development
(blue: chymase). 150 mmol/L borax-borate buffer, pH 8.5, containing
8 mmol/L dipyridyl, 5 mmol/L ethylenediaminetetra-In immunodouble staining for chymase/Leu 4, one
primary unlabeled antibody (chymase) and one fluores- acetic acid (EDTA) and 770 mmol/L diisopropyl phos-
phorofluoridate. Angiotensin II converted from angio-cein isothiocyanate (FITC)-conjugated antibody (Leu 4)
were used [19]. The procedure was as follows: chymase tensin I was determined using reversed-phase column
[20]. The protein concentration was measured by proteinantibody, alkaline phosphatase-conjugated goat anti-
mouse immunoglobulin (Dako), normal mouse serum assay reagent (Pierce Chemical Company, Rockford, IL,
USA), using BSA as the standard.(Dako), FITC-conjugated Leu4 antibody (Becton and
Dickinson), FITC-conjugated goat anti-rabbit immuno-
Statistical analysisglobulin (Dako), and peroxidase-conjugated goat anti-
rabbit immunoglobulin (Dako). Alkaline phosphatase The results are expressed as mean 6 SE. Comparisons
between two groups were performed using the unpairedwas visualized with fast blue BB (blue: chymase) and the
peroxidase with 3-amino-9-ethylcarbazole development Student t test and between $3 groups using analysis
of variance (ANOVA) followed by Fisher’s PLSD test.(red: Leu4).
Antibody/enzyme conjugates were diluted in Tris-HCl Associations between variables were evaluated using
Spearman’s correlation coefficient. P values of less than(50 mmol/L, pH 7.8)-buffered saline (TBS) 1 1% bovine
serum albumin (BSA). TBS washings were performed 0.05 were considered significant.
between all steps (three times 2 minutes), and all incuba-
tions were performed at room temperature.
RESULTS
Quantitative analysis of tryptase-positive MCs andMorphometric analysis
chymase-positive MCsThe number of tryptase-positive MCs, chymase-posi-
tive MCs, or IL-4–positive cells within the surface area of Normal kidneys. Normal kidneys, as controls, con-
tained only occasional MCs, which were preferentiallythe cortex of each transplanted or normal kidney was quan-
titated, using a computerized morphometry system, Mac- located in areas adjacent to interstitial vessels. Quantita-
tively, the mean number of tryptase-positive MCs inSCOPE Ver 2.2 (Mitani Corporation, Fukui, Japan) and
expressed as the absolute number of tryptase-positive normal kidneys was 1.08 6 0.35, and that of chymase-
positive MCs was 0.58 6 0.30 (Table 2).MCs, chymase-positive MCs, or IL-4-positive cells per
1 mm2 surface area. Rejected kidneys. All rejected kidneys, including both
nephrectomy and biopsy specimens, contained abundantIn each nephrectomy specimen of transplanted kidneys,
the surface area occupied by macrophages was quanti- MCs scattered throughout the thickened interstitium.
Each of these rejected kidneys, moreover, showed mas-tated by use of the computerized morphometry system
and was expressed as a percentage of the total surface sive infiltration of macrophages and T lymphocytes in
the interstitium.area of cortex, the so-called macrophage area. The sur-
face area occupied by T lymphocytes—the so-called T (a) Nephrectomy specimens. The mean number of
tryptase-positive MCs was significantly higher (P , 0.05)lymphocyte area—was quantitated in a similar fashion
and was likewise expressed as a percentage of the surface in 13 nephrectomy specimens of rejected kidneys
(12.04 6 2.32) than in normal kidneys. Of the 13 nephrec-area of the cortex.
The degree of interstitial fibrosis in the transplanted kid- tomy specimens, 12 showed a marked increase in the
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Table 2. Quantification of chymase- and tryptase-positive correlations between the number of chymase-positive
mast cells in rejected kidneys
MCs and the interval from transplantation to biopsy.
Morphometric analysis
numbers/mm2 Enzymatic assay for chymase activity
Sample N Tryptase Chymase Chymase activity in normal or rejected kidney tissues,
Normal kidneys 4 1.0860.35 0.5860.30 as determined by the capacity to convert angiotensin I
Rejected kidneys to angiotensin II, showed similar trends to those in mor-
Nephrectomy specimens
phometric examinations (Fig. 2). Chymase activity inChy(2) group 5 9.1062.44 0.4060.18
Chy(1) group 8 13.8863.40a 12.0362.65b,c the Chy(1) group was measured with six nephrectomy
Biopsy specimens specimens, because two nephrectomy specimens had in-
Chy(2) group 1 9.00 0.51
trarenal hemorrhage inhibiting chymase activity due toChy(1) group 4 14.6063.64a 9.0062.27a
serpines, which are chymase inhibitors in blood. Chy-a P , 0.05 vs. normal kidneys
b P , 0.01 vs. normal kidneys mase activity in the Chy(1) group exhibited a more than
c P , 0.01 vs. Chy(2) group of nephrectomy specimens 21-fold increase compared with those of normal kidneys
(P , 0.01) and a more than 6.5-fold increase compared
with those of the Chy(2) group (P , 0.01; Fig. 2).
number of tryptase-positive MCs. However, the re-
Mast cell phenotypes
maining one (case N-12) revealed normal range in the
Nephrectomy specimens. In 12 of the 13 nephrectomynumber of tryptase-positive cells, although this case
specimens, but not case N-12, both MCt and MCtc phe-showed an increased number of MCs histologically.
notypes were found in the interstitium (Fig. 3A). TheThe number of chymase-positive MCs varied widely in
percentages of the MCtc phenotype in the total MCthe nephrectomy specimens. No significant correlations
counts were 7.40 6 3.46% in the Chy(2) group andwere found between the number of chymase-positive
75.69 6 11.02% in the Chy(1) group.MCs and the interval from transplantation to hemodialy-
In contrast, specimens of case N-12 contained abun-sis, that from transplantation to nephrectomy, or that
dant chymase-positive but tryptase-negative MCs (MCcfrom hemodialysis to nephrectomy.
phenotype; Fig. 3B), which were histologically identifiedBased on chymase positivity, the 13 nephrectomy spec-
as MCs using an astra blue/safranin and toluidine blueimens were divided into two groups: (1) the chymase-
stain. The immunodouble staining for chymase and c-kitnegative group [Chy(2) group] and (2) the chymase-
clearly demonstrated that these MCs of the MCc pheno-positive group [Chy(1) group]. The first group (N 5 5)
type were positive for c-kit (Fig. 4A). Moreover, thehad an increase in the number of tryptase-positive MCs,
immunodouble staining for endothelial cells (or macro-
but chymase expression in MCs was low, as in normal
phages, or T lymphocytes) and chymase revealed that
kidneys. The number of tryptase-positive MCs in this chymase positivity was not detected in these endothelial
group increased more than eightfold compared with that cells, macrophages, and T lymphocytes (Fig. 4B–D).
of normal kidneys, but the difference between these two Biopsy specimens. In all biopsy specimens, both MCt
groups was not statistically significant (Table 2). In the and MCtc phenotypes were observed in the interstitium.
second group (N 5 8), the number of chymase-positive The percentages of MCtc phenotype in the total MC
MCs in each allograft was more than fourfold compared counts were 5.70% in the Chy(2) group and 63.85 6
with that of normal kidneys (Fig. 1A). In this group, 10.96% in the Chy(1) group.
the number of chymase-positive MCs was significantly
higher (P , 0.01) than in the control and Chy(2) groups Degree of interstitial fibrosis
(Table 2). Nephrectomy specimens. All nephrectomy specimens
With regard to the macrophage area and the T lym- of the rejected kidneys showed interstitial fibrosis, but
phocyte area, there were no statistically significant differ- of various degrees, associated with atrophy and a de-
ences between the Chy(1) group and the Chy(2) group. crease in tubules, renovascular stenosis caused by intimal
(b) Biopsy specimens. The mean number of tryptase- thickening, and infiltration of inflammatory cells (Fig. 5).
positive MCs in the five biopsy specimens (13.48 6 3.04) The degree of interstitial fibrosis was independent of the
was significantly higher (P , 0.01) than in normal kid- interval between transplantation and nephrectomy. No
neys. Based on chymase positivity, biopsy specimens significant correlation was found between the degree of
were also divided into a Chy(2) group (N 5 1) and a interstitial fibrosis and the number of tryptase-positive
Chy(1) group (N 5 4; Table 2). In the Chy(1) group MCs. However, there was a positive and significant cor-
of biopsy specimens, the number of chymase-positive relation between the degree of interstitial fibrosis and
MCs was significantly higher (P , 0.05) than in normal the number of chymase-positive MCs (R 5 0.745, P ,
0.01). Moreover, the rate of fibrosis in the Chy(1) groupkidneys (Fig. 1B and Table 2). There were no significant
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Fig. 5. Sections showing the degree of interstitial fibrosis. (A) Chy(2)Fig. 1. Sections showing mast cell (MC) chymase expression in human
group. Azan Mallory stain shows mild fibrosis of the interstitium. (B)rejected kidneys. (A) Staining for chymase (red), nephrectomy speci-
Chy(1) group. Azan Mallory stain reveals marked fibrosis of the inter-men of the Chy(1) group. (B) Staining for chymase (red), biopsy
stitium with the disappearance of tubules. Original magnification 3160specimen of the Chy(1) group. Both nephrectomy and biopsy speci-
(A and B).mens show increased numbers of chymase-positive MCs. Original mag-
nification 3150 (A and B).
Fig. 3. Sections showing three mast cell (MC) phenotypes: MC con-
taining tryptase (MCT), MC containing tryptase and chymase (MCTC),
and chymase-positive and tryptase-negative MC (MCC). (A) Immuno-
double staining (tryptase, red/chymase, blue). A cell (long arrow) shows
double staining (purple), indicating that this is a MC of MCtc pheno-
type. A cell (short arrow) with positivity for only tryptase (red) repre-
sents a MC of MCt phenotype. (B) Immunodouble staining (tryptase, Fig. 7. Section showing interleukin-4 (IL-4) expression. Immunodou-
red/chymase, blue), case N-12. Most cells (arrowheads) show staining ble staining (IL-4, red/chymase, blue). IL-4 positivity is detected in a
positivity for only chymase (blue), indicating that these cells represent chymase-positive MC (arrow, purple) and some T lymphocytes (red).
MCs of the MCc phenotype. A cell (short arrow) with positivity for Original magnification 3620.
only tryptase (red) reveals a MC of the MCt phenotype. Original
magnification 3630 (A and B).
was significantly higher than that in the Chy(2) group
(Figs. 5 and 6).
Biopsy specimens. Similar results were obtained in
the biopsy specimens. Morphometric analysis revealed
marked fibrosis in the Chy(1) group [Chy(1) group
(N 5 4), 16.13 6 2.7%; Chy(2) group (N 5 1), 7.87%].
Expression of IL-4
In the nephrectomy specimens, the number of IL-4–
positive cells in the Chy(1) group exhibited a more than
28-fold compared with that in the Chy(2) group (P ,
0.01; Table 3). The immunodouble staining for IL-4 and
chymase, moreover, revealed that IL-4 was expressed in
some of the T lymphocytes and chymase-positive MCs
(Fig. 7).
Fig. 4. Sections showing c-kit expression and chymase positivity in the
interstitium. (A) Immunodouble staining (c-kit, red/chymase, blue).
Most cells (arrows) show double staining (purple); chymase-positive DISCUSSION
MCs are positive for c-kit. (B) Immunodouble staining (endothelial
Previous studies have revealed increased numbers ofcell, red/chymase, blue). (C) Immunodouble staining (macrophage, red/
chymase, blue). (D) Immunodouble staining (T lymphocyte, red/chy- MCs in renal allografts, using toluidine blue stain or
mase, blue). Endothelial cells, macrophages, and T lymphocytes do not simply an antitryptase antibody [3–5]. However, no re-
show double staining (purple), indicating no chymase positivity in these
ports have been able to provide information on the pro-endothelial cells, macrophages, and T lymphocytes. Original magnifica-
tion 3720 (A) and 3450 (B–D). tease heterogeneity of MCs because formalin fixation is
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Fig. 2. Chymase activity in normal and rejected kidneys. Vertical
whisker bars represent SEM. N indicates the number of analyzed speci-
mens. *P , 0.01.
Fig. 6. Quantitation of the fibrotic interstitium in the cortex of rejected
kidneys. Vertical whisker bars represent SEM. N indicates the numberan unreliable criterion for distinguishing between the of nephrectomy specimens analyzed. *P , 0.01.
types of MCs, particularly chymase-positive MCs [6, 15].
Thus, there have been no data regarding chymase-posi-
tive MCs in renal allografts. The present study, which
Table 3. Quantification of interleukin-4 (IL-4)–positiveused immunodouble staining techniques and was based
cells in nephrectomized kidneys
on nephrectomy and biopsy specimens obtained from
Morphometric analysispatients with chronic rejection, is the first to demonstrate
Nephrectomy specimens N numbers/mm2
that chymase is expressed in MCs of human rejected
Chy(2) group 5 1.2661.17kidneys. Chy(1) group 8 36.3765.99a
The ability to distinguish the types of human MCs in
a P , 0.01 vs. Chy(2) group
the same section clearly is a crucial step toward better
understanding the role of these MC phenotypes under
diverse pathological conditions. It is widely accepted that
in humans there are two phenotypes of MCs, designated that protease phenotypes of human MCs in culture are
MCt and MCtc [6]. However, recent reports have dem- regulated by cytokines [13, 21] and that the chymase
onstrated that a third MC phenotype, tryptase-negative expression in human MCs is strongly promoted by IL-4
and chymase-positive type, designated MCc, is present [14]. These experimental data and our present findings
in human tissues [10–12]. The present study supports support the hypothesis that cytokines produced within
this concept, and to the best of our knowledge, the pres- the microenvironment may play a role in chymase ex-
ence of MCc phenotype in human rejected kidneys also pression of human MCs in tissue.
is another first demonstration. Chymases in mammals, including humans, have been
A number of previous experimental studies have sug- shown to be stored in secretory granules of MCs [22, 23].
gested that a relationship may exist between human MC Recently, Urata et al reported that the presence of chy-
maturation and protease expression, and that there may mase-like immunoreactivity was observed in multiple
be factors that up-regulate chymase expression along cell types, including endothelial cells, interstitial mesen-
with promotion of human MC maturation [13, 14, 21]. chymal cells, and MCs in the human heart [24]. However,
In the present study, we found that the number of IL-4– the present study using immunodouble staining analysis
positive cells in the Chy(1) group was significantly demonstrated that endothelial cells of vessels in human
higher than that in the Chy(2) group. This observation renal allografts did not show positive immunostaining
suggests that enhanced expression of IL-4 may be linked for chymase. The reason for the discrepancy between the
to the increase of chymase expression in MCs in human findings of Urata et al and our own is not clear. It might
be attributed to the difference in experimental condi-transplanted kidneys. Recent in vitro studies have shown
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